1.0Division of Gastroenterology and Hepatology/medicine/gigsa/medicine/gi/author/gsa/rich600338<blockquote class="wp-embedded-content" data-secret="5PrSPT4aYt"><a href="/medicine/gi/people/kimberly-c-darlington-md-phd/">Kimberly C. Darlington, MD, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/medicine/gi/people/kimberly-c-darlington-md-phd/embed/#?secret=5PrSPT4aYt" width="600" height="338" title="“Kimberly C. Darlington, MD, PhD” — Division of Gastroenterology and Hepatology" data-secret="5PrSPT4aYt" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /medicine/gi/wp-content/uploads/sites/1267/2021/12/R_W7MW84cAHVpUIX7_KDarlington-Headshot.jpg600480General interest is in defining novel diagnostic and therapeutic approaches for IBD. A major focus is defining molecular signatures of patients with UC and CD and determining how these may be used inform rational use of available therapies. The goal of both the molecular and outcomes research is to further optimize and develop new treatments … Read more